Replication Stable and RNase Resistant Chimeras of Pestivirus with Insertion in 3' Nontranslated Region (3'NTR)

a chimera and rnase technology, applied in the field of rnase resistant chimeras of pestivirus with insertion in the nontranslated region, can solve the problems of presenting additional technical difficulties in analytical rna assays, the inability to obtain internal quantification or quantification standards (qs) materials from naturally occurring sources, and the use of potentially infectious materials for humans is not desirable in diagnostic kits

Inactive Publication Date: 2010-05-27
LIFE TECH CORP
View PDF17 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0023]This invention provides RNA viral chimeras with insertions in the 3′NTR as quality control material, including use as controls, standards and calibrators in RNA viral analytical NAT assays.

Problems solved by technology

While PCR and other NAT techniques can test both DNA and RNA, there are technical challenges especially with quality control for RNA assays: 1) RNA is generally more labile than DNA, presenting additional technical difficulties for analytical RNA assays as compared to DNA assays.
It may not be combined, however, with the test sample to be used as an internal control or quantitative standard, because it would cause a false positive signal.
3) The use of materials potentially infectious for humans is not desirable in a diagnostic kit due to safety concerns and shipping regulations.
4) Internal Quality Standards (IQS) like Internal Controls (IC) and internal Quantification or Quantitation standards (QS) materials often can not be obtained from naturally occurring sources.
While it is known to transcribe RNA sequences from recombinant DNA sequences, it is difficult to package and protect these RNA transcript sequences from degradation by RNases.
Armored RNA also is utilized as a high titer HCV surrogate material, since it is not possible to grow all different HCV subtypes in culture.
Armored RNA has several disadvantages for use as a quality control material in analytical assays.
In this case the result could be a false negative blood screening result for HIV resulting in the transfusion of HIV positive CD4 blood cells to several recipients.
If the chimeric viral RNA replicates improperly, spontaneous sequence changes, such as deletions or frameshifts, may occur during replication in the RNA sequence of the virus chimera to form useless sequence revertants or pseudo-revertants.
The ultimate genomic sequence of the revertant virus is unpredictable and may exclude part or parts of the applied insert.
Unstable chimeric RNA virus, therefore, is usually not useful as a quality control material in an analytical RNA assay.
Rice et al., therefore, did not construct a replication competent BVDV chimera with insertion within the 3′NTR that was genetically stable and could be grown in culture.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Replication Stable and RNase Resistant Chimeras of Pestivirus with Insertion in 3' Nontranslated Region (3'NTR)
  • Replication Stable and RNase Resistant Chimeras of Pestivirus with Insertion in 3' Nontranslated Region (3'NTR)
  • Replication Stable and RNase Resistant Chimeras of Pestivirus with Insertion in 3' Nontranslated Region (3'NTR)

Examples

Experimental program
Comparison scheme
Effect test

example 1

Construction of BVDV-Non-CP7 cDNA and Generation of Infectious Non-Cytopathic Viral RNA

[0074]A modified cDNA of BVDV (type-1) strain CP7 was generated as a starting material for all subsequent procedures (Becher et al., 2000 J. Virol. 74: 7884-7894). The modification was performed such that the CP7 insert (Tautz et al., J Virol. 1996 November; 70(11):7851-8) was removed to create a cDNA containing plasmid that encoded a BVDV “non-CP7” RNA biotype (M. Behrens, unpublished data). A similar construct was published earlier by Makoschey et al., (Vaccine, 2004, Sep. 3; 22(25-26):3285-94.) The complete sequence of the cDNA for the BVDV-non-CP7 is given as SEQ ID NO: 1.

[0075]The plasmid encoding the BVDV-non-CP7 cDNA was linearized by restriction digestion with the restriction endonuclease SmaI. In vitro transcripts were generated by run-off transcription using SP6 RNA polymerase. The viral RNA was generated by in vitro transcription using SP6 RNA polymerase. The in vitro generated BVDV-non...

example 2

Generation of Chimeric BVDV-Non-CP7 cDNAs

[0076]The plasmid including the BVDV-non-CP7 cDNA (SEQ ID NO: 1) was then used to introduce the HCV 5′NTR sequence (HCV Coni cDNA; Lohmann et al., 1999) within the BVDV 3′NTR to obtain a functional chimeric viral sequence (BVDV-non-CP7-HCV 5′NTR).

[0077]For that purpose, a synthetic DNA fragment was generated commercially. This DNA fragment corresponded to the ClaI (initiating at pos. 11047 of the BVDV-non-CP7 cDNA sequence) / SmaI (initiating at pos. 12264 of BVDV-non-CP7 cDNA sequence) fragment of the BVDV-non-CP7 cDNA (SEQ ID NO:1), but also included an HCV 5′NTR insert (Con 1 subtype 1 b isolate; Lohmann et al., 1999, Science. Jul. 2: 285 (5424): 110-3) flanked by two restriction sites (SnaBI and PacI) and an additional TAA trinucleotide. The cDNA sequence of the HCV 5′NTR is given in SEQ ID NO: 2. This heterologous insert was positioned such that in corresponding RNA transcripts it was located between the UGApos.cons. box and the SLII stem-...

example 3

Stability of the cDNA Plasmid Constructs of the Newly-Generated Pestivirus BVDV Chimeras

[0082]Several individually isolated cDNA plasmids encoding either BVDV-non-CP7 (SEQ ID NO: 1), the BVDV-non-CP7+ cloning site chimera (SEQ ID NO: 4), or the BVDV-non-CP7-HCV 5′NTR chimera (SEQ ID NO: 3) were grown in E. coli. The plasmids were prepared using standard procedures and the authenticity of the inserts was verified by DNA sequencing. The overall stabilities of the plasmids through several passages in E. coli were verified by performing restriction analysis using multiple restriction enzymes and sequencing.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
lengthaaaaaaaaaa
temperaturesaaaaaaaaaa
temperaturesaaaaaaaaaa
Login to view more

Abstract

The invention relates to the field of nucleic acid amplification, particularly to quality control materials for use in viral RNA assays. It specifically relates to the construction of a recombinant Pestivirus by the identification of a region in the 3′NTR of the viral RNA genome where additional sequence elements can be stably inserted. Chimeric Pestivirus with sequence insertions in the 3′ nontranslated region (3′NTR) of the viral RNA genome were stable in replication and capable of forming infectious, RNase resistant virus particles. This chimeric Pestivirus with a 3′NTR insertion can be utilized as a quality control material in analytical assays for RNA targets, including external, internal controls, quantitative standards in PCR and NAT nucleic acid assays.

Description

BACKGROUND OF THE INVENTION[0001]An RNA virus has RNA (ribonucleic acid) as its genetic material, and infects host cells from bacteria, plants or animals, such as livestock and humans. The major criteria of how RNA viruses are classified are the sense and organization of the viral genome that determines the mode of viral RNA replication, including whether the viral RNA genome has positive (message) or negative sense, whether it is single or double stranded, and whether it is non-segmented or segmented.[0002]Regulatory agencies often require that assays for detection of nucleic acids utilize quality control materials, including standards, calibrators and controls (Molecular Diagnostic Methods for Infectious Diseases; Approved Guideline, 2nd ed., Clinical and Laboratory Standards Institute, vol 26 (8), 2006). Quality control materials insure optimum performance and reliability of test results, including nucleic acid test (NAT) assays. Laboratories are required to demonstrate that assa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): C12N5/06C07H21/02C12N15/63
CPCC12N7/00C12N2770/24211C12N2770/24222C07H21/02C12N2770/24322C12N15/86C12N2770/24311
Inventor SCHOENBRUNNER, ERHARD RALFBEHRENS, SVEN-ERIK
Owner LIFE TECH CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products